Other Team Members

ex. Nurses, case managers, medical assistants, office managers

Drug Safety Communications - FDA warns about dental problems with buprenorphine medicines dissolved in the mouth to treat opioid use disorder and pain

This is an FDA warning that dental problems have been reported with medicines containing buprenorphine that are dissolved in the mouth. Despite these risks, buprenorphine is an important treatment option for opioid use disorder (OUD) and pain, and the benefits of these medicines clearly outweigh the risks.

What Can Primary Care Services Do to Help First Nations People with Unhealthy Alcohol Use? A Systematic Review: Australia, New Zealand, USA and Canada

Reviews 28 studies about alcohol treatments delivered in primary care settings, finding that trials of naltrexone and disulfiram had positive results, but that more studies are needed to assess the effectiveness of the full scope of alcohol treatment